car-t as a second-line therapy in the lymphoma treatment landscape
Published 2 years ago • 140 plays • Length 2:06Download video MP4
Download video MP3
Similar videos
-
1:17
the impact of car-t therapy in the second-line setting in lymphoma
-
1:33
second-line car-t therapy in b-cell lymphoma
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
10:21
advances in car-t therapy for lymphoma
-
7:40
immunotherapy for aml and all: checkpoint inhibitors & car t-cells for b-cell all
-
6:54
the future of car-t therapy in the management of dlbcl
-
0:59
axi-cel as second-line therapy for r/r large b-cell lymphoma
-
1:15
the benefits of second-line car-t cell therapy
-
1:25
bringing car t-cells to the second-line setting
-
1:35
the role of car-t therapy in high-risk lbcl in the first and second-line settings
-
2:30
car-t as a new standard of care in lymphoma
-
2:10
new algorithm for second-line dlbcl: the role of car-t therapy
-
1:08
the benefits of car-t therapy in 2l over 3l in r/r dlbcl
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
1:39
the role of myeloid cells in car-t cell therapy
-
1:17
changes in second-line lymphoma treatment
-
2:34
car-t & bispecific antibodies in second-line dlbcl
-
2:09
the role of car-t therapy in hematologic malignancies
-
1:20
limitations of car t-cell therapy for dlbcl